Physician profile
Carol E Ritter
NPI 1376537282
$4,595.08
in general payments reported to CMS, 2019-2025
37 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $589 · 2021: $722 · 2022: $1,200 · 2023: $783 · 2024: $487 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.15 |
| Education | $196.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $855.01 | 2019-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $622.89 | 2019-2022 | |
| Abbvie INC. | $622.80 | 2019-2024 | Orilissa, Liletta |
| Pfizer INC. | $395.12 | 2019-2023 | |
| Exeltis, USA INC. | $290.82 | 2019-2025 | Slynd |
| Myovant Sciences INC. | $270.95 | 2022 | |
| Millicent US INC | $171.45 | 2019-2025 | Femring, Intrarosa |
| Lilly USA, LLC | $160.92 | 2020-2021 | |
| Avion Pharmaceuticals | $127.60 | 2019-2023 | Balcoltra |
| Exact Sciences Corporation | $103.46 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $99.78 | 2021-2023 | Ova1 |
| Amag Pharmaceuticals, INC. | $91.09 | 2019 | |
| Mayne Pharma Commercial LLC | $72.62 | 2021-2022 | |
| Daiichi Sankyo INC. | $72.53 | 2021-2022 | |
| Allergan, INC. | $70.28 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $66.19 | 2019-2020 | |
| Duchesnay USA Incorporated | $51.86 | 2019 | |
| Vertical Pharmaceuticals, LLC | $44.19 | 2019 | |
| Sage Therapeutics, LLC | $37.64 | 2024 | |
| Mission Pharmacal Company | $37.36 | 2019-2022 | |
| Boston Scientific Corporation | $31.67 | 2023 | Solyx Sis System |
| Evofem Biosciences, INC. | $28.99 | 2022 | |
| Shield Therapeutics INC | $26.66 | 2023 | Accrufer |
| Mylan Pharmaceuticals INC. | $26.15 | 2022 | |
| Aesculap, INC. | $25.40 | 2019 | |
| Organon LLC | $25.01 | 2022 | |
| Coopersurgical, INC. | $19.65 | 2023 | Mara Console |
| Merck Sharp & Dohme LLC | $18.42 | 2019 | |
| Lupin INC. | $16.99 | 2019 | |
| Scynexis, INC. | $16.35 | 2022 | |
| Applied Medical Resources Corporation | $16.33 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $15.83 | 2023 | Vivjoa |
| Hologic Sales and Service, LLC | $15.78 | 2021 | |
| Medline Industries Lp | $14.51 | 2022 | |
| Sumitomo Pharma America, INC. | $14.04 | 2023 | Myfembree |
| Minerva Surgical, INC | $12.14 | 2020 | |
| Meditrina | $6.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Ritter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.